TABLE 6.
Clinicopathologic Features of Patients Who Received Adjuvant Chemotherapy or Chemotherapy Followed by Radiation After Upfront Resection of Pancreatic Cancer
Categorical Variable | Chemo | Chemo-RT | P Value |
---|---|---|---|
Median survival (mo) | 42.7 | 54.6 | 0.247 |
Grade | |||
1 | 70 (13.6%) | 72 (14.1%) | 0.418 |
2 | 298 (58.0%) | 296 (57.8%) | |
3 | 142 (27.6%) | 134 (26.2%) | |
4 | 4 (0.8%) | 10 (1.9%) | |
Stage | |||
1 | 173 (32.0%) | 164 (30.3%) | 0.840 |
2 | 367 (67.8%) | 376 (69.5%) | |
3 | 1 (0.2%) | 1 (0.2%) | |
T | |||
1 | 52 (9.7%) | 44 (8.3%) | 0.418 |
2 | 118 (22.1%) | 116 (21.8%) | |
3 | 363 (68.0%) | 371 (69.7%) | |
4 | 1 (0.2%) | 1 (0.2%) | |
Comorbidities | |||
No | 356 (65.8%) | 361 (66.7%) | 0.748 |
Yes | 185 (34.2%) | 180 (33.3%) | |
Tumor size (mm) | 36.1±61.8 | 33.9±45.2 | 0.517 |
# of examined nodes | 14.9±9.2 | 14.9±8.9 | 0.976 |
Cohort of propensity score matching of patients with no high-risk features (negative margin, no nodal involvement, and no lymphovascular invasion).
All the treatments are in the adjuvant setting. Categorical variables presented in number (%) and continuous variables presented as meanstandard deviation.
Chemo indicates chemotherapy; Chemo-RT, chemotherapy followed by radiation.